1. Current Therapeutic Strategies and Challenges in Nsclc Treatment: A Comprehensive Review;Kumar;Exp Oncol,2022
2. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of;Howington;Chest Physicians evidence-based clinical practice guidelines. Chest.,2013
3. Immune Resistance in Lung Adenocarcinoma;Spella;Cancers (Basel),2021
4. KRAS(G12C)/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (>/=50%) lung adenocarcinoma;Frost;Transl Lung Cancer Res,2021
5. Antiproliferative and Proapoptotic Effects of Phenanthrene Derivatives Isolated from Bletilla striata on A549 Lung Cancer Cells;Zhou;Molecules,2022